![logo](/logos/NVCT.webp)
Nuvectis Pharma, Inc.
NASDAQ:NVCT
6.94 (USD) • At close July 26, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Nuvectis Pharma, Inc. |
Symbool | NVCT |
Munteenheid | USD |
Prijs | 6.94 |
Beurswaarde | 127,391,056 |
Dividendpercentage | 0% |
52-weken bereik | 5.85 - 15.5 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ron Bentsur M.B.A. |
Website | https://www.nuvectis.com |
An error occurred while fetching data.
Over Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)